Results 201 to 210 of about 747,425 (295)

Meeting Report on an Integrated Research Agenda for Mosquito-Borne Arboviruses. [PDF]

Open Forum Infect Dis
Ulrich AK, Moua NM, Mack A, Imai-Eaton N, Staples JE, Mehr AJ, Ostrowsky JT, Leighton T, Cehovin A, Fay PC, Golding JP, Maynard E, Alphey L, Rojas Alvarez DP, Coffey LL, Faria NR, Maciel-de-Freitas R, Maringer K, Murray KA, Salje H, Sang R, Vasconcelos PFC, Leo YS, Sinkins SP, de Vasconcelos JN, Dadzie SK, Harris E, Dos Santos TH, Velayudhan R, Wongsawat J, Osterholm MT, Lackritz EM.   +31 more
europepmc   +1 more source

The Role of Calcitonin Gene‐Related Peptide in High‐Altitude Headache: A Prospective Field Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective High‐altitude headache (HAH) is a common neurological condition associated with rapid ascent to high altitude. The pathophysiological mechanisms underlying HAH remain incompletely understood. Calcitonin gene‐related peptide (CGRP), a neuropeptide implicated in migraine pathophysiology, may play a key role in the pathophysiology of ...
Roman Schniepp, Ludwig Karrasch, Helena Breitenstein, Andreas Straube, Katharina Kamm   +4 more
wiley   +1 more source

World Sight Day 2025 at Dr. Sumait Hospital, Mogadishu, Somalia: Meeting Report of a Community Eye Screening and Expert Panel. [PDF]

Clin Optom (Auckl)
Omar AA, Mohamed IA, Mohamed AA.
europepmc   +1 more source

Relationship Between Neurologic Symptoms and Signs and FMR1 Genotype in Premutation Carriers

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background and Objectives Fragile X‐associated Tremor/Ataxia Syndrome (FXTAS) is the most severe late‐onset condition caused by a premutation in the FMR1 gene, characterized by expanded CGG triplet repeats of 55–200. Clinical presentations of FXTAS, including gait ataxia, kinetic tremor, cognitive decline, and rare Parkinsonism, are linked to ...
Flora Tassone, Freddy Chafota, Miguel E. Rentería, Randi J. Hagerman, Ellery Santos, Anna Atkinson, Nicholas G. Martin, Elsdon Storey, Danuta Z. Loesch   +8 more
wiley   +1 more source

Meeting report of the GlySpace Alliance and GaLSIC symposium. [PDF]

Glycobiology
Aoki-Kinoshita KF, Lisacek F, Mazumder R, Ranzinger R, Tiemeyer M, Yamada I, Packer NH.   +6 more
europepmc   +1 more source

Effectiveness of rTMS on Working Memory and Inhibitory Impairments in Patients With Post‐Stroke Executive Deficits

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Considerable efforts have been dedicated to developing effective treatments for post‐stroke executive impairment (PSEI), among which repetitive transcranial magnetic stimulation (rTMS) has shown great potential. This study aimed to investigate the therapeutic effects of high‐frequency rTMS on working memory (WM) and response ...
Mengting Lao, Rongwei Du, Zhujun Wang, Yang Gao, Meiling Cheng, Xianglong Wang, Wen Wu   +6 more
wiley   +1 more source

Meeting report: the Human Genome Meeting (HGM) 2019 in Seoul, Korea

Human Genomics, 2019
Angela Solano, Giuseppe Novelli, Shruti Baghat, Piero Carnici, Gert-Jan van Ommen, Juergen K. V. Reichardt   +5 more
doaj   +1 more source

International fluoride symposium: effects of fluoride on human health and its mechanisms of action - a meeting report. [PDF]

BMC Proc
Martinez-Mier EA, Castiblanco-Rubio GA, Tamayo-Cabeza G, Aguiar A, Bashash M, Bastain T, Brunst K, Breton C, Cantoral A, Figueroa JL, Goodman C, Hu H, Ibarluzea-Maurolagoitia J, Lanphear B, Malin A, Martinez M, Peterson KE, Roberts EFS, Schantz S, Subiza-Perez M, Tamayo-Ortiz M, Tellez-Rojo MM, Till C, Watkins DJ, Lippert F.   +24 more
europepmc   +1 more source

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich, Jonathan A. Gernert, Hanna Zimmermann, Lisa Tagnin, Marianthi Zeinaki, Laura Sanzo, Letizia Vogler, Elisabeth Kaufmann, Justina Dargvainiene, Frank Leypoldt, Gérard N. Bischof, Robert Perneczky, Boris‐Stephan Rauchmann, Simon Lindner, Günter U. Höglinger, Rudolf A. Werner, Martin Kerschensteiner, Tania Kümpfel, Matthias Brendel, Franziska S. Thaler   +19 more
wiley   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source